International Biotechnology Trust PLC Axogen, Inc. Transaction History

International Biotechnology Trust PLC

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2018 Nov 13, 2018	BUY	$34.05 - $55.9 $578,850 - $950,300	17,000 New	17,000 $1.9 Million
Q2 2018 Aug 13, 2018	SELL	$36.15 - $52.5 $1.81 Million - $2.63 Million	-50,000 Closed	0 $0
Q1 2018 May 15, 2018	BUY	$24.4 - $40.25 $1.22 Million - $2.01 Million	50,000 New	50,000 $1.82 Million

162

36.6M

230K

400

Ticker AXGN
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 42,283,700
Market Cap $661M
Description
AxoGen, Inc., together with its subsidiaries, develops and markets surgical solutions for physical damage or transection to peripheral nerves. The company's products include Avance Nerve Graft, a biologically active off-the-shelf processed human nerve allograft for bridging severed nerves without the comorbidities associated with a second surgic...

Get notified when there are updates to the investment portfolio of International Biotechnology Trust PLC, based on Form 13F filings with the SEC.

Stay updated on International Biotechnology Trust PLC with notifications on news.